Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$10.26
+4.5%		$12.90
$9.62
▼
$21.34
$695.04M-0.0110,381 shs10,492 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
+4.48%-20.22%-25.49%-36.55%-16.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$10.26
+4.5%		$12.90
$9.62
▼
$21.34
$695.04M-0.0110,381 shs10,492 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
+4.48%-20.22%-25.49%-36.55%-16.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
2.20
Hold$38.67276.87% Upside

Current Analyst Ratings Breakdown

Latest JOG, I3E, GENL, and PHAR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/3/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$37.00 ➝ $38.00
7/31/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/30/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
5/11/2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-) ➝ Sell (D)
(Data available from 8/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$376.13M1.93$0.21 per share48.96$3.82 per share2.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$2.85M$0.1285.5041.04N/A2.51%3.40%1.90%N/A

Latest JOG, I3E, GENL, and PHAR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$0.0630$0.02-$0.0430$0.02$99.52 million$90.20 million
5/7/2026Q1 2026
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
$0.05-$0.07-$0.12-$0.07$92.06 million$72.45 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.34
3.01
2.06

Institutional Ownership

CompanyInstitutional Ownership
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
0.03%

Insider Ownership

CompanyInsider Ownership
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
2.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
28070.78 million69.31 millionNot Optionable

Recent News About These Companies

Pharming Group (NASDAQ:PHAR) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says
August 5 at 1:06 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30941132
PHAR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Pharming Group (PHAR)
August 4 at 2:09 PM  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/08/04/10425106.htm
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
August 4 at 9:08 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/pharming-group-participate-canaccord-genuity-060000797.html
Canaccord Genuity Group Forecasts Strong Price Appreciation for Pharming Group (NASDAQ:PHAR) Stock
August 3 at 5:35 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/canaccord-genuity-group-forecasts-strong-price-appreciation-for-pharming-group-nasdaqphar-stock-2026-08-03/
HC Wainwright Lowers Earnings Estimates for Pharming Group
August 3 at 1:13 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30937173
Q3 EPS Estimates for Pharming Group Lowered by HC Wainwright
August 3 at 1:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/q3-eps-estimates-for-pharming-group-lowered-by-hc-wainwright-2026-08-03/
Pharming Group (NASDAQ:PHAR) Shares Gap Down After Earnings Miss
August 2 at 1:21 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30935266
Pharming Group (NASDAQ:PHAR) Hits New 12-Month Low Following Weak Earnings
August 1, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30933333
Pharming Group (NASDAQ:PHAR) Posts Earnings Results, Misses Expectations By $0.04 EPS
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-nasdaqphar-posts-earnings-results-misses-expectations-by-004-eps-2026-07-30/
Pharming Group Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Pharming Group (PHAR)
July 31, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/pharming-group-investigation-notice-levi--korsinsky-notifies-investors-of-pending-investigation-into-pharming-group-phar-302840307.html
Pharming Group (NASDAQ:PHAR) Shares Gap Down Following Weak Earnings
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-nasdaqphar-shares-gap-down-following-weak-earnings-2026-07-31/
Pharming Group N.V. (PHAR) Q2 2026 Earnings Call Transcript
July 30, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4928101-pharming-group-n-v-phar-q2-2026-earnings-call-transcript
Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader ...
July 30, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/pharming-reports-second-quarter-and-first-half-2026-financial-results-and-revises-year-end-guidance-strong-joenja-momentum-and-near-term-clinical-readouts-to-support-broader-therapeutic-use-1036383406
Pharming Group下调2026年营收指引3000万美元，销售疲软拖累业绩
July 30, 2026  |  cn.investing.comhttps://cn.investing.com/news/stock-market-news/article-93CH-3487282
Pharming Group mist Q2 2026 omzetverwachting, aandeel daalt 22%
July 30, 2026  |  nl.investing.comhttps://nl.investing.com/news/transcripts/pharming-group-mist-q2-2026-omzetverwachting-aandeel-daalt-22-93CH-870710
Pharming Group (NASDAQ:PHAR) Sets New 12-Month Low Following Weak Earnings
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-nasdaqphar-sets-new-12-month-low-following-weak-earnings-2026-07-30/
Pharming Group Q2 Earnings Call Highlights
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-q2-earnings-call-highlights-2026-07-30/
Pharming Group N.V. 2026 Q2 - Results - Earnings Call Presentation
July 30, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4927633-pharming-group-n-v-2026-q2-results-earnings-call-presentation
Earnings To Watch: Pharming Group (XAMS:PHARM) Q2 2026 -- GF Value Sees 36% Upside
July 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/earnings-watch-pharming-group-xams-140027227.html
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Short Interest Update
July 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-nv-sponsored-adr-nasdaqphar-short-interest-update-2026-07-27/
Pharming Group (PHAR) to Release Earnings on Thursday
July 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/pharming-group-phar-to-release-earnings-on-thursday-2026-07-23/

Media Sentiment Over Time

Top Headlines

View All Headlines
A semiconductor wafer with the SK hynix logo displayed inside a manufacturing fabrication facility.
SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
By Thomas Hughes | July 7, 2026
Rocket Lab Electron rocket on coastal launch pad with company logo overlay, symbolizing space tech integration strategy.
Rocket Lab’s Stock Drop Comes With a Bullish Twist
By Ryan Hasson | July 10, 2026
Two Very Large Crude Carriers (VLLCs) sailing side by side on open ocean waters, viewed from above.
Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
By Dan Schmidt | July 19, 2026
Trading screen displaying a candlestick price chart, options calls and puts pricing table, and green call, red put buttons.
The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
By Bridget Bennett | July 20, 2026
Open investment playbook on a desk with hand-drawn arrows, symbolizing sector rotation strategy for 2026 investing.
3 Overlooked Stocks Positioned for the Next Market Rotation
By Bridget Bennett | July 13, 2026
Pharming Group stock logo

Pharming Group NASDAQ:PHAR

$10.26 +0.44 (+4.48%)
Closing price 08/4/2026 03:52 PM Eastern
Extended Trading
$10.58 +0.32 (+3.12%)
As of 04:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas